Jonathan Allan
CIK: 0001966716
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Stoke Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (53 total)
- Oct 2, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct627 shares at avg. $26.33$17K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct145 shares at avg. $32.47$5K - Aug 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $32.01$87K - Aug 14, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct6K shares- - Jun 16, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $29.95$44K - Mar 20, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct8.7K shares at avg. $33.64$292K - Mar 20, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct601 shares at avg. $34.41$21K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct4.2K shares at avg. $31.28$132K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct334 shares at avg. $31.79$11K - Mar 18, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct72 shares at avg. $32.85$2K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.8K shares at avg. $33.38$60K - Mar 17, 2026STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.5K shares at avg. $32.74$81K - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct6K shares- - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct12K shares- - Mar 15, 2026STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct7.5K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
53K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
35K shares- - Dec 8, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $32.61$87K - Dec 8, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1.3K shares at avg. $31.60$41K - Dec 5, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct5.4K shares at avg. $31.08$169K - Dec 5, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct2.3K shares at avg. $31.76$74K - Dec 5, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct1K shares at avg. $31.33$31K - Dec 4, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct194 shares at avg. $31.32$6K - Dec 4, 2025STOK
Stoke Therapeutics, Inc.
Sale(S)Direct824 shares at avg. $30.76$25K - Dec 3, 2025STOK
Stoke Therapeutics, Inc.
Exercise(M)Direct6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 627 | $26.33 | $16,509 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 145 | $32.47 | $4,708 | Direct |
| Aug 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,716 | $32.01 | $86,932 | Direct |
| Aug 14, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 6,000 | - | $0 | Direct |
| Jun 16, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,457 | $29.95 | $43,637 | Direct |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 8,692 | $33.64 | $292,359 | Direct |
| Mar 20, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 601 | $34.41 | $20,679 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 4,222 | $31.28 | $132,080 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 334 | $31.79 | $10,617 | Direct |
| Mar 18, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 72 | $32.85 | $2,365 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,791 | $33.38 | $59,775 | Direct |
| Mar 17, 2026 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,476 | $32.74 | $81,063 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 6,000 | - | $0 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 12,000 | - | $0 | Direct |
| Mar 15, 2026 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 7,475 | - | $0 | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 53,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Restricted Stock Units | 35,000 | - | - | Direct |
| Dec 8, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,678 | $32.61 | $87,337 | Direct |
| Dec 8, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,300 | $31.60 | $41,074 | Direct |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 5,437 | $31.08 | $168,997 | Direct |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 2,344 | $31.76 | $74,445 | Direct |
| Dec 5, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 1,004 | $31.33 | $31,456 | Direct |
| Dec 4, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 194 | $31.32 | $6,075 | Direct |
| Dec 4, 2025 | STOK Stoke Therapeutics, Inc. | Sale(S) | 824 | $30.76 | $25,349 | Direct |
| Dec 3, 2025 | STOK Stoke Therapeutics, Inc. | Exercise(M) | 6,000 | - | - | Direct |
1-25 of 53 transactions
About Allan Jonathan
Allan Jonathan (SEC CIK 0001966716) files insider reports with the SEC as GENERAL COUNSEL & CORP SEC of Stoke Therapeutics, Inc. (STOK).
Signal8 holds 21 ownership filings by Allan Jonathan, all Form 4s, filed between Dec 3, 2024 and Oct 2, 2026. Those filings report 53 transactions, from Dec 1, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Allan Jonathan's filings is in BEDFORD, MA.
Recent filings by Allan Jonathan
- Oct 2, 2026: Open-market sale of STOK shares (Form 4, code S).
- Aug 18, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
- Aug 14, 2026: Option exercise of STOK shares (Form 4, code M).
- Jun 16, 2026: Open-market sale of STOK shares (Form 4, code S).
- Mar 20, 2026: Open-market sales of STOK shares (2 lines, Form 4, code S).
Other insiders filing for Stoke Therapeutics, Inc. (STOK)
- Ticho Barry, CHIEF MEDICAL OFFICER
- Cumbo Alexander, Director
- Kaye Edward M. MD, Director
- Harrison Seth Loring, Director
- McCauley Thomas, Chief Scientific Officer
- TZIANABOS ARTHUR, Director